Education Programs

Bridging knowledge and practice in dermatology: Implementing JAKis in real-world alopecia areata

This educational program provides practical, case-based guidance to help clinicians evaluate AA severity beyond percentage scalp hair loss, understand JAK inhibitor safety and efficacy, and integrate these treatments into personalized patient care.

Faculty Dr. Amy McMichael, Dr. Arash Mostaghimi

Target audience US-based dermatologists and advanced practice providers (APPs) who treat patients with alopecia areata.

A CGM roadmap ​for personalized ​diabetes care

A digital learning experience comprising a suite of CME- accredited activities, including realistic case-based e- learning modules and a real-world patient perspective video, each supported by a downloadable practice aid for reference in clinical practice.

Faculty Dr. Kirsten Flint, Prof. Samuel Seidu, Dr. Margaertha Visser

Target audience US-based primary care physcians, endocrinologists and the wider diabetes healthcare team

Amyloidosis action

A program offering expert guidance, practical tools and peer-led insights designed to support multidisciplinary teams in establishing and strengthening specialist amyloidosis services.

Faculty Prof. Marianna Fontana, Dr. Vaishali Sanchorawala, Prof. David Adams, Prof. María Adela Aguirre, Mrs Christine Chiti, Eugenia Cisneros-Barroso, Cristina Descals, Alejandra Gonzalez Duarte, Juan González-Moreno, Damian Heine Suñer, Dr. Yawara Kawano, Prof. María Adela Aguirre, Inés Losada, Dr. Paolo Milani, Dr. Roberta Mussinelli, Dr. Laura Obici, Prof. Dr. Sebastian Spethmann, Prof. Mitsuharu Ueda, Dr. Márcia Waddington

Target audience Neurologists, cardiologists, hematologists, gastroenterologists, orthopedic surgeons, nephrologists, geneticists, physiotherapists, psychologists, pathologists, nurses, and other HCPs involved in diagnosis and management of patients with amyloidosis

Pediatric endocrinology

Our aim is to report the most impactful research findings and provide focused updates of hot topics, with clinical context and expert commentary, to build knowledge and bridge the gap between research and patient care.

Target audience Paediatrics, Endocrinologists

Decoding HER2 mutations and overexpression in NSCLC

Expert-led resources to help build on knowledge, confidence, and competence in HER2 biomarker testing, implementing HER2-targeted therapies in practice, and managing brain metastases in patients with NSCLC

Target audience Oncologists, pathologists, pulmonologists and oncology nurses, physician assistants, and those in the multidisciplinary teams worldwide who provide front-line care for patients with NSCLC.

Awareness, advances, action: Optimizing outcomes for patients with generalized myasthenia gravis

Join Program Director Dr. Kelly Gwathmey and a faculty of leading experts and inspiring patient contributors as they highlight the value of a patient-centric approach to generalized myasthenia gravis (gMG) care.

Faculty Dr. Kelly Gwathmey, Dr. Pushpa Narayanaswami, Dr. Sithara Ramdas, Dr. Kara Stavros, RGN Jude KingsPatient contributors: Janel Worcester-Brown, Jodi Dudas, Caroline Ann Budzinski, Betty Ajueyitsi

Target audience Clinicians and nurse practitioners within the neurology, neuromuscular, or neuroimmunology disease space

Sharper focus: Advancing surgical decision-making with next-generation PC-IOLs

This free, three-part, CME-accredited educational program is designed to support ophthalmic surgeons in delivering optimal outcomes with PC-IOLs.

Faculty Dr. Jennifer Loh, Dr. Rahul Tonk, Dr. Caroline Watson

Target audience US-based ophthalmologists, optometrists, cataract and refractive surgeons performing lens-based surgery

Integrating ketone and glucose monitoring for optimized diabetes management

This CME-accredited Ketone Monitoring Masterclass, an on-demand digital learning experience, will update you on guidelines, pathophysiology of DKA, innovations in ketone monitoring, and overcoming barriers to ketone monitoring.

Faculty Dr. David Kerr, Dr. Jennifer Sherr, Dr. Eda Cengiz

Target audience US-based primary care physicians (PCPs) who are looking to improve their knowledge and skills in ketone monitoring technology for patients with T2D.

Re-defining frontline myeloma therapy: The emerging role of BCMA-directed strategies in newly diagnosed multiple myeloma

This COMy 2026 independent medical education symposium brought together an expert international faculty for an engaging and forward-looking discussion on how BCMA-directed therapies could reshape the frontline treatment paradigm in newly diagnosed multiple myeloma (NDMM).

Faculty Dr. Mohamad Mohty, Dr. María-Victoria Mateos, Prof. Florent Malard, Dr. Evangelos Terpos, Wendy Bursey

Target audience Global (excluding US) hematologists, oncologists, specialist nurses, and all other healthcare professionals (HCPs) managing multiple myeloma.

Biomarker-driven management of NSCLC

This expert-led program will help individualize management of NSCLC by providing education on biomarker testing for NTRK fusions and HER2 mutations, current evidence-based guidelines, and new and emerging targeted therapies.

Faculty Fernando Lopez-Rios, Prof Nicolas Girard, Dr Justin Gainor, Dr Luis Paz-Ares, Prof Sanjay Popat, Dr Lynette Sholl, Dr Caterina Marchiò, Dr Xiuning Le, Dr Alexander Drilon, Dr Sabina Berezowska

Target audience Oncologists, pathologists and those treating patients with NSCLC

The AML expert series: Innovations in molecular testing, emerging therapies & targeted treatments

A three-part video podcast series for hematologist-oncologists seeking to enhance their knowledge, skills, and practice in molecular testing, emerging therapies, and targeted treatments in relapsed/refractory (R/R) acute myeloid leukemia (AML).

Faculty Prof. Amer Zeidan, Dr. Sanam Loghavi, Prof. Courtney D. DiNardo, Dr. Eunice Wang

Target audience Oncologists/hematologists, pathologists, and the multidisciplinary team involved in the diagnosis, interpretation of test results, treatment, and management of patients with AML.

Unveiling the spectrum: A deep dive into late-onset genetic cholestasis

This expert-led program will allow you to effectively recognize and diagnose late-onset genetic cholestasis and its associated conditions, and make informed decisions on individualized patient management strategies, by providing education on disease presentation, the importance of genetic testing, symptom management, clinical guidelines, and new advances in the treatment landscape.

Faculty Dr Richard Thompson, Verena Keitel-Anselmino, Dr Deepak Doshi, Dr Silvia Vilarinho

Target audience Hepatologists and gastroenterologists

SLE: Translating Guidelines into Practice

Developed in collaboration with leading experts, this program aims to help physicians confidently implement the latest evidence-based strategies in lupus care addressing key challenges in management of SLE management worldwide.

Faculty Prof. Martin Aringer, Prof. Marta Mosca, Dr. Johanna Mucke, Dr. Wiebke Troll (patient)

Target audience Rheumatologists, Dermatologists, Nephrologists, Cardiologists, Neurologists, Gastroenterologists, and the wider global multidisciplinary team that manages SLE patients

Integrating tumor microenvironment biology with clinical impact: Evolving understanding of therapeutic approaches for MF‑CTCL

This on-demand, interactive, CME-accredited symposium examines the role of the tumor microenvironment (TME) in mycosis fungoides–type cutaneous T-cell lymphoma (MF-CTCL), its influence on disease progression and therapeutic response, and how these insights can inform precision-informed treatment selection.

Faculty Dr. Larisa J. Geskin, Dr. Christiane Querfeld, Dr. Sima Rozati, Dr. Francine Foss

Target audience Dermapathologists​, dermatologists, medical oncologists, oncodermatologists

Next generation MRI contrast agents: Preparing the field

A special focus on MRI contrast agents and their role in modern diagnostic imaging, exploring what is changing, and how to translate emerging evidence into clinical practice to optimise patient care

Faculty Prof. Minerva Becker, Dr. Kottler, Prof. Carlo C Quattrocchi, Dr. Giles Roditi, Dr. Àlex Rovira

Target audience Radiologists, neuroradiologists, radiographers, MRI physicians, and imaging technologists, neurologists and cardiologists.